Á¦ 10ȸ ´ëÇÑÈ­Çпä¹ýÇÐȸ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê À§¿øȸ ȸÀÇ·Ï Ç×»ýÁ¦ Stewardship ¿¬±¸È¸ °Ô½ÃÆÇ

Á¦ 10ȸ ´ëÇÑÈ­Çпä¹ýÇÐȸ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê À§¿øȸ ȸÀÇ·Ï
±è½Å¿ì 2015-10-07 151
Á¦ 10ȸ ´ëÇÑÈ­Çпä¹ýÇÐȸ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê À§¿øȸ ȸÀÇ·Ï ÀϽÃ: 2015³â 10¿ù 7ÀÏ, Àå¼Ò: ¼­¿ï¿ª ÀÌÁî¹Ì Âü¼®ÀÚ: ±è½Å¿ì(°æºÏ´ëº´¿ø), ±è¹ÎÁ¤(°æºÏ´ëº´¿ø), À̹̼÷ (°æÈñÀÇ·á¿ø), À±¿µ°æ(°í´ë¾È¾Ïº´¿ø), ÃÖ¿ø¼®(°í´ë¾È»êº´¿ø), ±èÁöÀº (ÇѾç´ë ±¸¸®º´¿ø), À±ÁöÇö(À»Áö´ëÇк´¿ø) ÃÑ 7¸í 1. ³íÀÇ 1, ÃÖ±Ù ÀÌ·ç¾îÁø ÀÏ ¨ç ÀåÇöÇÏ, ±è½Å¿ì µî HBIGÅõ¿©°¡ ¾ðÁ¦±îÁö È¿°ú¸¦ °¡Áö³ª? How long duration are acceptable for HBIG administration as postexposure prophylaxis after Hepatitis B needle stick injury? American Journal of Infection Control¿¡ accepted ¨è ±è¹ÎÁ¤, ±è½Å¿ì µî, °¨¿°Áúȯ Áø·á ½Ã Èñ±ÍÀǾàÇ° »ç¿ëÀÇ ÇöȲ°ú °³¼±ÇÒ Á¡ ´ëÇѳ»°úÇÐȸ accepted 2015³â 11¿ù ¿¹Á¤ ¨é Yoon, Y. K., Jo, Y. M., Kwon, H. H., Yoon, H. J., Lee, E. J., Park, S. Y., ... & Kim, S. W. Differential diagnosis between tuberculous spondylodiscitis and pygenic spontaneous spondylodiscitis: a multicenter descriptive and comparative study. The Spine Journal. 2015, 15(8), 1764–1771 ¨ê ±èÇýÀÎ, ±è½Å¿ì, ÀåÇöÇÏ, & ±èÈ«ºó. Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥¿¡ ´ëÇÑ ¼³¹®Á¶»ç. A Survey of Antimicrobial Stewardship Programs in Korean Hospitals, Korean Journal of Medicine 2014, 87(2), 173-181 ¨ë Young Kyung Yoon, Jacob Lee, Seong Yeol Ryu, Hyun-Ha Chang, Won Suk Choi, Ji Hyun Yoon, Jian Hur, Yu Mi Jo, Sue-yun Kim, Kyung Sook Yang, Shin-Woo Kim. Clinical significance of multidrug-resistant Acinetobacter baumannii isolated from central venous catheter tip cultures in patients without concomitant bacteremia Scandinavian Journal of Infectious Diseases, December 2013, 45(12), 900-906 ¨ì Pseudomonas ±ÕÇ÷Áõ ¿¬±¸, °¨¿°ÇÐȸ ÃÊ·Ï ³¿, À±¿µ°æ Ãß°¡Àû ´Ù¸¥ ºÐ¼® ¿¹Á¤, ÀûÀýÇÑ Ç×»ýÁ¦ÀÇ Á¤ÀǸ¦ °¨¼ö¼ºÀÌ ÀÖ´Â ¾àÁ¦¿¡¼­ ºÒÇÊ¿äÇÏ°Ô ³ÐÀº ¹üÀ§ÀÇ Ç×»ýÁ¦ »ç¿ë°ú Á» Á¼Àº ¹üÀ§ÀÇ Ç×»ýÁ¦ »ç¿ë µîÀ» ºñ±³ÇÏ´Â °Í °í·Á (ÃÖ¿ø¼® »ù ÀÇ°ß) 2. ¹Ì·ç¾îÁø °í·ÁÁßÀÎ ÁÖÁ¦ ¨ç Áö¿ª»çȸȹµæÆó·Å¿¡¼­ ampicillin/sulbactam ¶Ç´Â amoxicillin/clavulanate vs. 3rd cepha ºñ±³: e-CRF¿¡ ÀÔ·Â (ÈÄÇâÀû ¿¬±¸) ¨è MSSA ±ÕÇ÷Áõ¿¡ cefazolin vs. nafcillin vs. ampi/sulbactam ¨é ÁÖ¿ä±ÕÀÇ ³»¼º±ÕÀÇ ³»¼º°ú Ç×»ýÁ¦ »ç¿ë·®ÀÇ °ü°è¿¡ ´ëÇÑ ¿¬±¸: ¨ê Ertapenem »ç¿ëÀ¸·Î Ä«¹ÙÆä³Û ³»¼ºÀÇ °¨¼Ò °¡´ÉÇÑ°¡? ÀÓ»óÀû È¿°ú, °æÁ¦Àû È¿°ú ¨ë Tigecycline »ç¿ëÀ¸·Î Ä«¹ÙÆä³Û ³»¼ºÀ» ÁÙÀÏ ¼ö Àִ°¡? 3. »õ·Î¿î ¿¬±¸ ÁÖÁ¦ 1) ±è½Å¿ì µî ¨ç ÆÐÇ÷Áõ Ä¡·á¿¡¼­ hydrocortisoneÀÇ ¿ªÇÒ: CRP 10 À̻󱺿¡¼­ Áö¿ª»çȸ°¨¿°¿¡ ±¹ÇÑ, ¼ºÀÎ (18¼¼ ÀÌ»ó), source¿¡ µû¸¥ Ãß°¡ ºÐ¼® °¡´ÉÇϵµ·Ï ¿¬±¸ÁÖÁ¦ ÇÁ·ÎÅäÄÝÀ» ³ª´©°í ³»³â º½±îÁö ¿¬±¸¸¦ ÁøÇà ¨è Syphilis Ä¡·á¿¡¼­ doxycycline vs, Benzathine PcGÀÇ ºñ±³ ¨é ³»¼º¼¼±Õ (3¼¼´ë cepha ³»¼º ±×¶÷À½¼º±Õ, MRSA)¿¡ ÀÇÇÑ Ã´Ãß¿°ÀÇ À§ÇèÀÎÀÚ¿Í ¿¹ÈÄ ÀÎÀÚ ¨ê Candida arthritisÀÇ ¿¹ÈÄ¿Í ±× °ü°èÀÎÀÚ ¨ë Prosthetic joint infectionÀÇ °æÇèÀû Ä¡·á¿¡ glycopeptide´Â ÇÊ¿äÇÑ°¡? ¨ì Spine ¼ö¼ú ÈÄ infectionÀÇ °æÇèÀû Ä¡·á¿¡ glycopeptide´Â ÇÊ¿äÇÑ°¡? 2) ÃÖ¿ø¼® µî ÇâÈÄ Áö¼ÓÀûÀº ÁÖÁ¦¸¦ °¡Áö°í ¿¬±¸ÇÏ´Â °Í ÇÊ¿ä ¿¹: Áö¿ª»çȸ °¨¿°ÀÇ ³»¼ºÀ²À» ÁÖ±âÀûÀ¸·Î Á¶»ç, ÀüÇâÀûÀÌ ÁÁÀ¸³ª ÈÄÇâÀûµµ ±âÁØÀ» Á¦ÇÑÀûÀ¸·Î ÇÏ¿© °¡´É, ´ëÀå±Õ µî ƯÁ¤±ÕÀÇ ³»¼ºÀ²À» ÁÖ±âÀûÀ¸·Î Á¶»ç, ¼ø¼öÇÑ Áö¿ª»çȸ°¨¿°¸¦ ȹµæÇϱâ À§Çؼ­ Á¤ÀǸ¦ ±¸Ã¼ÀûÀ¸·Î Á¼°ÔÇÏ´Â °ÍÀÌ ÇÊ¿ä Catchment populationÀ» ÀÌ¿ëÇÑ °¨¿°ÀÇ ¹ß»ýÀ² Á¶»ç ¿¬±¸ °í·Á 4. ±âŸ ÅäÀÇ Tedizolid Àӻ󿬱¸ Á¦¾ÈÀ» MSD¿¡ ÇÒ °ÍÀΰ¡? ¸» °ÍÀΰ¡?: ºÎÁ¤Àû Àå±âÀû ¹ßÀüÀ» À§ÇÑ ÆݵåÀÇ È®º¸°¡ ´õ ÇÊ¿ä ±×·¯³ª ¿¬±¸ ³×Æ®¿öÅ©·Î¼­ÀÇ Á¸ÀçÀǹ̰¡ ¿ì¼±ÀûÀ¸·Î Áß¿ä 5. ´ÙÀ½ ¸ðÀÓ: 3°³¿ù µÚ °èȹ